Literature DB >> 8419666

Smoking and risk of Graves' disease.

M F Prummel1, W M Wiersinga.   

Abstract

OBJECTIVE: To assess if smoking is associated with Graves' disease and, if so, to ascertain whether this association persists when controlling for confounding factors.
DESIGN: Consecutive entry case-control study with two age- and sex-matched control subjects from two different populations per case patient.
SETTING: University hospital. PATIENTS: Five groups were studied: (1) Graves' ophthalmopathy and Graves' hyperthyroidism (n = 100; divided in four subgroups according to the severity of the eye disease); (2) Graves' hyperthyroidism without clinical eye involvement (n = 100); (3) sporadic nontoxic goiter (n = 100); (4) autoimmune hypothyroidism (n = 75); and (5) toxic nodular goiter (n = 75). The study comprised 200 subjects from a hospital-based population, and 200 from a population-based group served as control subjects. MAIN OUTCOME MEASURE: Smoking status was determined from a questionnaire at the time of onset of the disease to exclude any effect of the disease itself on smoking.
RESULTS: Smoking greatly increased the risk for Graves' ophthalmopathy (odds ratio, 7.7; 95% confidence interval, 4.3 to 13.7), but patients with Graves' hyperthyroidism alone were also more often smokers than control subjects (odds ratio, 1.9; 95% confidence interval, 1.1 to 3.2). Smoking was not associated with the other thyroid diseases studied. Essentially similar results were obtained after adjustment for differences in education between case patients and control subjects. Among the patients with Graves' ophthalmopathy, smokers had more severe eye disease than nonsmokers, but no association was found between the number of cigarettes smoked per day or the duration of smoking and the severity of the ophthalmopathy. However, there was a significant increase in the odds ratios in patients with more severe eye disease.
CONCLUSIONS: Smoking is associated with Graves' disease, and it especially increases the risk for the development of more severe ophthalmopathy. Thus, smoking appears to be one of the multiple factors inducing Graves' disease in genetically predisposed individuals.

Entities:  

Mesh:

Year:  1993        PMID: 8419666

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  81 in total

1.  Diabetes mellitus: a risk factor in patients with Graves' orbitopathy.

Authors:  R Kalmann; M P Mourits
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

2.  Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy.

Authors:  B M Hosal; J K Swanson; C R Thompson; S Kubota; K Gunji; J S Kennerdell; J R Wall
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

Review 3.  Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.

Authors:  Kimberley P Cockerham; John S Kennerdell
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

4.  Smoking and Graves' disease.

Authors:  Luigi Bartalena
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

5.  Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy.

Authors:  I M Wakelkamp; M N Gerding; J W Van Der Meer; M F Prummel; W M Wiersinga
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 6.  Relationship between cigarette smoking and Graves' ophthalmopathy.

Authors:  L Hegediüs; T H Brix; P Vestergaard
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

7.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

8.  Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study.

Authors:  Brenton G Yuen; Vivien M Tham; Erica N Browne; Rachel Weinrib; Durga S Borkar; John V Parker; Aileen Uchida; Aleli C Vinoya; Nisha R Acharya
Journal:  Ophthalmology       Date:  2015-03-30       Impact factor: 12.079

Review 9.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 10.  Prevalence and natural history of Graves' orbitopathy in the XXI century.

Authors:  E Piantanida; M L Tanda; A Lai; L Sassi; L Bartalena
Journal:  J Endocrinol Invest       Date:  2013-04-16       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.